CardiaTec Biosciences
Cambridge
About CardiaTec Biosciences
CardiaTec is a TechBio business that uses computational tools to unravel the biology underlying cardiovascular illness. CardiaTec uses massive and high-dimensional human omics data to better understand complicated disease biology and identify novel and differentiated therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.2M
- Funding stage: Seed
- Last round: Seed (Sep 2024)
- Website: cardiatec.ai
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cardiatec-biosciences-127491 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.